Safe Orthopaedics Granted CE Mark for Sycamore Osteoporotic Fracture Treatment
Sycamore is a minimally invasive, ready-to-use technology that improves the first treatment of one or more fractures....
May 24, 2021,
Safe Orthopaedics Granted CE Mark for Sycamore Osteoporotic Fracture Treatment
Prosidyan Gains CE Mark for FIBERGRAFT Bone Grafts
FIBERGRAFT BG Putty, FIBERGRAFT BG Putty GPS and FIBERGRAFT BG Morsels are intended for use in the lumbar and anterior...
May 21, 2021,
Paragon 28 Launches 3 Families of Demineralized Bone Matrix
The company introduced BEAST Injectable, BEAST PLUS and BEAST Osteobiologic Sponge for bone grafting applications in the foot and ankle....
May 21, 2021,
Preparing for the Next Big Orthopedic Supply Chain Interruption
OEM and contract manufacturer executives share that businesses can prepare for disruptions by fostering resilient plans, leadership and teams....
May 20, 2021,
2 Orthopedic Companies Go Public in 2021
Bioventus and Treace Medical Concepts are two very different companies seeking to be leaders within their respective spaces....
May 20, 2021,
13 Orthopedic Companies Receive Funding
Companies across orthopedics with products in development or recently cleared continue to secure funding to fuel commercialization efforts....
May 20, 2021,
Interim Study Results: Treace ALIGN3D Clinical Study
ALIGN3D is evaluating the Lapiplasty 3D Bunion Correction System to treat Hallux Valgus....
May 20, 2021,
Biogennix Agilon Moldable Bone Graft Available Throughout the U.S.
The product surged in popularity and usage in 2021, largely driven by its positive reception from the foot and ankle...
May 20, 2021,
VIVEX Biologics Launches VIAGENEX Family of Allografts
VIAGENEX has application as a soft tissue barrier in clinical settings such as shoulder, nerve, knee and tendon repair....
May 20, 2021,
Software Update for CorinConnect Orthopedic Ecosystem
The worldwide release enables surgeon access to analytical data from pre-, intra- and post-operative technologies....
May 20, 2021,
Loading new posts...
No more posts
